‌

US Patent 10723733 Hepatitis B antiviral agents

Patent 10723733 was granted and assigned to Enanta Pharmaceuticals on July, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 28, 2020

Patent Application Number

16210492

Date Filed

December 5, 2018

Patent Citations

US Patent 10189846 Hepatitis B antiviral agents

US Patent 10428070 Hepatitis B antiviral agents

US Patent 10179131 Hepatitis B antiviral agents

US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound

Patent Citations Received

0

US Patent 11891393 Functionalized heterocycles as antiviral agents

0

US Patent 12011425 Hepatitis B antiviral agents

0

US Patent 11472808 Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents

US Patent 11596611 Hepatitis B antiviral agents

US Patent 11760755 Hepatitis B antiviral agents

US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

US Patent 11377450 Functionalized heterocycles as antiviral agents

Patent Primary Examiner

Alexander R Pagano

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10723733 Hepatitis B antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.